Orlando FL 重度抑郁症临床试验
19项针对 重度抑郁症的研究正在 Orlando及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
招募中3 期
- Nova Psychiatry INC, Orlando
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
招募中2 期
- Clinical Neuroscience Solutions Inc. - Orlando, Orlando
- K2 Medical Research - Maitland, Maitland · 距离 6 英里
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
招募中3 期
- Accel Research Sites - Maitland, Maitland · 距离 6 英里
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
招募中2 期
- Seaport Investigator Site, Orlando
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
招募中2 期
- Clinical Neuroscience Solutions, Inc., Orlando
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
招募中2 期
- Draig Clinical Site, Orlando
- Draig Clinical Site, Orlando
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
招募中2 期
- Draig Clinical Site, Orlando
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
招募中3 期
- Clinical Neuroscience Solutions, LLC (Orlando), Orlando
- Charter Research, Orlando
- K2 Medical Research (Maitland), Maitland · 距离 6 英里
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Maitland · 距离 6 英里
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
招募中3 期
- Charter Research - Orlando, Orlando
- K2 Medical Research - Maitland, Maitland · 距离 6 英里
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
招募中3 期
- Clinical Neuroscience Solutions, Inc., Orlando
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
招募中2 期
- Clinical Neuroscience Solutions, Inc., Orlando
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Orlando
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Maitland · 距离 6 英里
- Neurocrine Clinical Site, Maitland · 距离 6 英里
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
招募中2 期
- Clinical Neuroscience Solutions - Orlando - East South Street /ID# 277558, Orlando
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Maitland · 距离 6 英里
Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
招募中
- AdventHealth Neuroscience Institute, Orlando
Study of ALTO-300 in MDD
招募中2 期
- Site 159, Clermont · 距离 24 英里
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
招募中4 期
- Clinical Research Site, Orlando
- Clinical Research Site, Orlando
- Clinical Research Site, Orlando
其他城市的 重度抑郁症试验
- New York City, NY37 项研究
- Boston, MA31 项研究
- Atlanta, GA25 项研究
- Philadelphia, PA23 项研究
- Miami, FL18 项研究
- Chicago, IL17 项研究
- Tampa, FL17 项研究
- Houston, TX16 项研究
- San Diego, CA16 项研究
- Little Rock, AR14 项研究
- Orange, CA13 项研究
- Austin, TX13 项研究
Orlando的其他研究
- 非小细胞肺癌44 项研究
- 肥胖症31 项研究
- 转移性癌症29 项研究
- 超重27 项研究
- 阿尔茨海默病25 项研究
- 2型糖尿病24 项研究
- 癌症（所有类型）24 项研究
- 乳腺癌23 项研究
- 卵巢癌22 项研究
- 溃疡性结肠炎22 项研究
- 肺癌21 项研究
- 结直肠癌19 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。